Wenqing Lu
Overview
Explore the profile of Wenqing Lu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
53
Citations
554
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Dai T, Guo K, Zhao J, Lu W
Geospat Health
. 2022 Dec;
17(2).
PMID: 36468587
Providing equal geographical access to hospitals, either in the public or private healthcare sector, is vital and will benefit public health in general. Against the background of the partial privatization...
12.
Lu D, Ding X, Lu W
Emerg Med Int
. 2022 Sep;
2022:2482728.
PMID: 36158765
Background: Osteoarthritis (OA) is a common chronic disease with numerous and interacting influencing factors, and current inadequate patient perceptions and behaviors in access to care contribute to the difficulties in...
13.
Shen L, Lin C, Lu W, He J, Wang Q, Huang Y, et al.
Cell Biol Toxicol
. 2022 Sep;
39(4):1377-1394.
PMID: 36087186
Colorectal cancer (CRC) is a common malignant cancer worldwide. Although the molecular mechanism of CRC carcinogenesis has been studied extensively, the details remain unclear. Small nucleolar RNAs (snoRNAs) have recently...
14.
Xu S, Wu Y, Chen Y, Lu W, Wang Y, Gao B, et al.
Sci Total Environ
. 2022 May;
838(Pt 2):155860.
PMID: 35595136
Environmental metal exposure has been associated with decreasing semen quality, but the effects of multiple metal exposure on seminal plasma metabolome remain obscure. In this study, semen and repeated urine...
15.
Shen L, Lu W, Huang Y, He J, Wang Q, Zheng X, et al.
Biomed Res Int
. 2022 May;
2022:8260800.
PMID: 35586811
Colorectal cancer (CRC) is presenting a global public health problem with high incidence and mortality. Early diagnosis and treatment are the most important strategies to improve prognosis of this disease....
16.
He Q, Lu J, Liu N, Lu W, Li Y, Shang C, et al.
Nanomaterials (Basel)
. 2022 Mar;
12(6).
PMID: 35335803
Coronavirus disease 2019 (COVID-19) has spread rapidly and led to over 5 million deaths to date globally. Due to the successively emerging mutant strains, therapeutics and prevention against the causative...
17.
Jin Y, Che X, Qu X, Li X, Lu W, Wu J, et al.
Front Oncol
. 2021 Dec;
11:783320.
PMID: 34869038
[This corrects the article DOI: 10.3389/fonc.2020.01612.].
18.
Yu G, Lu W, Jiao Z, Qiao J, Ma S, Liu X
World J Surg Oncol
. 2021 Oct;
19(1):305.
PMID: 34663341
Background: Some clinical researchers have reported that patients with cCR (clinical complete response) status after neoadjuvant chemoradiotherapy (nCRT) could adopt the watch-and-wait (W&W) strategy. Compared with total mesorectal excision (TME)...
19.
Wang D, Qu X, Lu W, Wang Y, Jin Y, Hou K, et al.
Front Oncol
. 2021 Jul;
11:681280.
PMID: 34277426
Abnormal RNA m6A methylation is known to lead to the occurrence and progression of multiple cancers including gastric cancer (GC). However, the integrative effects of all m6A methylation regulators on...
20.
Wang Y, Zheng C, Lu W, Wang D, Cheng Y, Chen Y, et al.
Front Oncol
. 2021 Mar;
11:620154.
PMID: 33763356
Patients with EGFR-mutant non-small-cell lung cancer (NSCLC) greatly benefit from EGFR-tyrosine kinase inhibitors (EGFR-TKIs) while the prognosis of patients who lack EGFR-sensitive mutations (EGFR wild type, EGFR-WT) remains poor due...